One of our predictions at the start of the year was that 2013 would be a year for pharma to make big moves in mobile health. European pharmaceutical company AstraZeneca has begun that process, announcing a pilot, in partnership with Exco InTouch, to address chronic obstructive pulmonary disease (COPD...
Clinical trials are a clear area where mobile engagement and big data have serious potential, but it’s still a largely untapped use case. There have been a lot of stories recently about the opportunities in that space, but also on the challenges companies have encountered in implementing them....
Tue, Nov 20 2012
Filed under: Filed under: Uncategorized, Vodafone, Exco InTouch, Epocrates, Pfizer, sanofi, Pfizer REMOTE clinical trial, TransCelerate BioPharma, TrialReach, StopWatch Media, goBalto, TrialX, Healogica, Partnering to End Pain, Genetic Alliance, Mytrus, Registry for All Diseases
The FDA just announced the approval of Xeljanz (tofacitinib) for rheumatoid arthritis. Read more here . We should see some interesting discussions about this given that the 2012 ACR/ARHP Annual Meeting is right around the corner. Read More...
Pfizer's profits, health law changes go into effect, suit over bill collecting from patients gets settled
Merkle, a customer relations management (CRM) company has acquired San Francisco-based 5th Finger, a mobile marketing and mobile health vendor for an undisclosed sum. While 5th Finger has a number of big retail brands as clients, including Jos. A Bank and Safeway, it has also powered Pfizer, Medtronic...
At the DIA Annual Meeting in Philadelphia last month, Vodafone and Exco InTouch announced a deal that sees Vodafone launching a new mobile-enabled clinical trial offering that leverages Exco’s patient reported outcomes software for mobile phones. Exco made headlines last year when it inked a deal...
This morning's health news ranges from the ramifications of a Supreme Court decision on the 201o health overhaul to the rising influence of pharmacists and the loss of valuable tissue used in autism research.
Here's what's making health news this morning:
J&J's CEO vows to fix the manufacturing problems resulting in Tylenol recalls and other health news grabbing headlines this morning.
If you don’t think this is a dispiriting time to be in Big Pharma, you obviously haven’t spent time with anyone who works there, laboring in the trenches. I have – in fact, I’ve spent the last several days at a professional workshop with a number of colleagues from a range of companies – and [...] Read...
Fri, Mar 16 2012
Filed under: Filed under: health, Pharma & Healthcare, Innovation & Science, byline=David Shaywitz, Pharma, Pfizer, big pharma, Building the Organization of Tomorrow, ticker=NASDAQ:AMZN, ticker=NASDAQ:GOOG, Celgene, ticker=NASDAQ:CELG, Gilead, ticker=NYSE:PFE, ticker=NASDAQ:GILD
In a press release Feb 1, the pharmaceutical company Pfizer announced a voluntary nationwide recall of certain packages of oral contraceptive pills. The issue had to do with specific packaging issues, resulting in the possibility of inexact tablet counts...
ALZHEIMER'S CHALLENGE 2012: SEEKING NEW TOOLS TO HELP IMPROVE ALZHEIMER’S CARE New Challenge Seeks Simple, Widely-Adaptable Tools to Track Alzheimer’s Progression and Support HHS “Triple Aim” of Better Care and Better Health at Lower Cost SOUTH SAN FRANCISCO (January 26, 2012) – Janssen Alzheimer...
In the last week, 250 apps were released into the health and medical categories of the App store; 134 belonged to the health & fitness category and 116 in the medical category.
We found eight apps of this week’s 250 to be noteworthy. They include offerings from three big name consumer brands...
Fri, Nov 18 2011
Filed under: Filed under: Uncategorized, iPhoneECG, Pfizer, AMA, My Medications, Robitussin Relief Finder, YES WE RUN, e.p.t. Ovulation Calculator, Dialysis Finder, Get Hydrated, fastECG, Glooko Logbook